Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Other Operating Expenses (2020 - 2025)

Historic Other Operating Expenses for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to $4.8 million.

  • Insight Molecular Diagnostics' Other Operating Expenses fell 4178.17% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.5 million, marking a year-over-year increase of 6816.35%. This contributed to the annual value of $41.7 million for FY2024, which is 72274.79% up from last year.
  • Latest data reveals that Insight Molecular Diagnostics reported Other Operating Expenses of $4.8 million as of Q3 2025, which was down 4178.17% from $4.3 million recorded in Q2 2025.
  • Insight Molecular Diagnostics' Other Operating Expenses' 5-year high stood at $29.4 million during Q4 2024, with a 5-year trough of -$11.4 million in Q1 2023.
  • Over the past 5 years, Insight Molecular Diagnostics' median Other Operating Expenses value was $3.3 million (recorded in 2021), while the average stood at $3.6 million.
  • As far as peak fluctuations go, Insight Molecular Diagnostics' Other Operating Expenses plummeted by 70190.27% in 2023, and later soared by 249550.56% in 2025.
  • Over the past 5 years, Insight Molecular Diagnostics' Other Operating Expenses (Quarter) stood at $9.1 million in 2021, then tumbled by 43.09% to $5.2 million in 2022, then soared by 128.14% to $11.8 million in 2023, then skyrocketed by 149.99% to $29.4 million in 2024, then crashed by 83.8% to $4.8 million in 2025.
  • Its Other Operating Expenses was $4.8 million in Q3 2025, compared to $4.3 million in Q2 2025 and $2.1 million in Q1 2025.